Standard recommendations for the application of Chinese clinical cell therapy for neurorestoration (2012)

Cell Transplant. 2013:22 Suppl 1:S5-10. doi: 10.3727/096368913X672082. Epub 2013 Aug 29.

Abstract

Cell therapy has been shown to be a promising alternative therapy for neurorestoration, and more than 30 different types of cells have been shown to possess some capability to restore lost or damaged neurological functions. Chinese physicians have successfully applied cell therapy to many neurological diseases and damages in the clinic and contributed to establish a discipline of neurorestoratology. To standardize the clinical procedures of cell therapy as one of the strategies for treating neurological disorders, the Chinese Branch of the International Association of Neurorestoratology (IANR) and the Preparatory Committee of Chinese Association of Neurorestoratology recently completed the Standard Recommendations (2012) for the Application of Chinese Clinical Cell Therapy for Neurorestoration. We hope these recommendations will guide clinical practice in applying cell therapy for neurorestoration, which will therein offer a reference for both Chinese and other countries' governments to make relevant official regulations. This manuscript is published as part of the International Association of Neurorestoratology (IANR) supplement issue of Cell Transplantation.

Publication types

  • Review

MeSH terms

  • Cell- and Tissue-Based Therapy / methods*
  • Cell- and Tissue-Based Therapy / standards*
  • Central Nervous System / physiology*
  • China
  • Humans
  • Nerve Regeneration / physiology*
  • Nervous System Diseases / therapy
  • Neurology / methods
  • Practice Guidelines as Topic
  • Regenerative Medicine / methods